https://www.nih.gov/coronavirus
[13]. Dae Gyann Ahn, et.al(2011) Interference of Ribosomal Frame shifting by antisera peptide nucleic acids suppresses SARS ,Corona virus replication, Elsevier 91(1):p:1-10.
[14] Jei Cui , Fang Li and Zang Li Shi(2018) Origin and Evolution of Pathogenic Coronaviruses, Nature Review Microbiology, 17:p:181-192.
[15] F. Amana & F. Krammer (2020) Immunity 52:, p:583–589
[16] Felix Boecker and Karin Moelling (2019) Evolution of Immune Systems from Viruses and Transposable Elements. Frontier of Microbiology, Virology, 29 Jan;; CRISPER-Cas a nd RAG ½ T-cell diversity
[17] Mitch Leslie (2020) T-Cell formed in Covid-19, patients “bode cell” for long term Immunity, Science, 14 May.
[18] Bonny Rochx et. al (2020) Comparative Pathogenesis of Covid-19 MERS, SARS in a non-human Primate Model, Science, April.
[19] Amanda Heits, (2020), Giant Viruses are not alive. So why have the stolen gene essential for life, Science, April.
[20] Dominika Hobernik and Matgias Bros, (2018), DNA Vaccine-How Far From Clinical use. Int. J. Mol. Science, 19(11):, 3605.
[21An updated guide to the coronavirus drugs and vaccines in development By Damian Garde@damiangarde, March 2020 Moderna Therapeutics Approach: Vaccine, ASM Communications
[22]. Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S (9 April 2020). ”The COVID-19 vaccine development landscape”. Nature Reviews Drug Discovery. 19 (5): 305–306.
[23] Jonathan Corum, Knvul Sheikh and Carl Zimmer, May 20, 2020 Different Approaches to a Coronavirus Vaccine
[24] Timothy R. Abbott, Girija Dhamdhere, Yanxia Liu, Xueqiu Lin, Laine Goudy, Leiping Zeng, Augustine Chemparathy, Stephen Chmura, Nicholas S. Heaton, Robert Debs, Tara Pande, Drew Endy, Marie La Russa, David B. Lewis, Qi, Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza doi: https://doi.org/10.1101/2020.03.13.991307, Cold Spring Harbor Laboratory,Biorexiv.
[25] Tim Abbott, Could Crispr Be Humanity’s Next Virus Killer? Stanford scientists are exploring whether gene-editing technology can be used to fight pandemics. But so far, they have just one piece of a larger puzzle. Science, Stanford University, 2020.